Asia: Demand for Creapure increases® significantly
The consequences of COVID-19 are also having an impact on the dietary supplement market: Supported by positive experiences, the market for Creapure® has been developing more and more strongly for some time in the direction of preventive health management. In addition, there has been an increase in demand for the dietary supplement Creapure® out of professional sports and increasingly into active mass sports.
This is also reflected, among other things, in the increased demand for Creapure® in the Asian end consumer market - especially in India.
Together with Ace International LLP, the new local distribution partner, Alzchem is working intensively to serve this market with its strong increase in demand and its special circumstances in the best possible way.
Incidentally, Alzchem also registered great interest and high demand for Creapure® at the 16th FI - Food Ingredients trade fair in Bangalore/India in September.
Contact
Robert Alber
About Alzchem
Alzchem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. Alzchem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, Alzchem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.